Richard W Pascoe's Net Worth
$828 Thousand
Who is Richard W Pascoe?
Richard W Pascoe does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include KEMPHARM, INC, Histogen Inc., SEELOS THERAPEUTICS, INC., Pernix Sleep, Inc., and ARIAD PHARMACEUTICALS INC.
SEC CIK
Richard W Pascoe's CIK is 0001343266
Past Insider Trading and Trends
2022 was Richard W Pascoe's most active year for acquiring shares with 9 total transactions. Richard W Pascoe's most active month to acquire stocks was the month of April. 2010 was Richard W Pascoe's most active year for disposing of shares, totalling 12 transactions. Richard W Pascoe's most active month to dispose stocks was the month of February. 2010 saw Richard W Pascoe paying a total of $233,700.00 for 440,000 shares, this is the most they've acquired in one year. In 2010 Richard W Pascoe cashed out on 410,291 shares for a total of $1,010,817.80, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
KEMPHARM, INC (ZVRA) Snapshot price: $7.26
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +50.07% | 10K |
$4.20 | $41,978.00 | 29.97K |
Mar 9
| |||
Form 4
| +90.71% | 9.5K |
$5.44 | $51,679.05 | 19.97K |
Jan 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 9
| |||
Form 4
| +152.21% | 5K |
$4.92 | $24,607.59 | 8.29K |
May 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 4
| +84.03% | 1.5K |
$7.88 | $11,822.10 | 3.29K |
Nov 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
| +53.84% | 10K |
$0.64 | $6,351.80 | 28.57K |
Aug 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 19
| |||
Form 4
| +92.57% | 8.93K |
—
|
—
| 18.57K |
Jun 30
| |||
Form 4
|
∞
| 9.64K |
—
|
—
| 9.64K |
May 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Histogen Inc. (HSTO) Snapshot price: $0.28
See Remarks
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
SEELOS THERAPEUTICS, INC. (SEEL) Snapshot price: $0.2305
CEO & Secretary
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 20
| |||
Form 4
| -22.38% | -44.81K |
$0.23 | -$10,149.46 | 155.4K |
Jan 23
| |||
Form 4
| -7.95% | -17.29K |
$0.31 | -$5,290.74 | 200.21K |
Nov 30
| |||
Form 4
| -3.41% | -7.68K |
$1.84 | -$14,129.36 | 217.5K |
Jan 1 - Jan 3
| |||
Form 4
| -7.70% | -18.79K |
$1.56 | -$29,312.40 | 225.18K |
Sep 5
| |||
Form 4
| +69.46% | 100K |
—
|
—
| 243.97K |
Jun 1
| |||
Form 4
| -2.51% | -3.71K |
$2.78 | -$10,319.36 | 143.97K |
Feb 15
| |||
Form 4
| +209.74% | 100K |
—
|
—
| 147.68K |
Jan 5
| |||
Form 4
| +276.07% | 350K |
—
|
—
| 476.78K |
Apr 25
| |||
Form 4
| +169.74% | 79.78K |
—
|
—
| 126.78K |
Mar 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 29
| |||
Form 4
| +27.03% | 10K |
$1.02 | $10,217.00 | 47K |
Dec 22
| |||
Form 4
| +48.00% | 12K |
$1.51 | $18,120.00 | 37K |
Oct 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 20
| |||
Form 4
| -28.57% | -10.00K |
—
|
—
| 25K |
Dec 30 - Feb 6
| |||
Form 4
|
∞
| 35K |
$2.85 | $99,750.00 | 35K |
May 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Pernix Sleep, Inc. No price found
President and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -98.29K |
—
|
—
|
0
|
Mar 6
| |||
Form 4
| +7.30% | 7.14K |
—
|
—
| 104.93K |
Dec 31
| |||
Form 4
| +92.53% | 50K |
—
|
—
| 104.03K |
Nov 16
| |||
Form 4
| +24.46% | 75.12K |
—
|
—
| 382.28K |
Sep 30
| |||
Form 4
| +33.13% | 76.44K |
—
|
—
| 307.16K |
Jul 2
| |||
Form 4
| -7.52% | -18.75K |
$0.48 | -$8,943.75 | 230.73K |
Scheduled
|
Jan 3
| ||
Form 4
| +5.64% | 11.1K |
$2.25 | $24,942.81 | 207.81K |
Jun 10
| |||
Form 4
| +174.32% | 125K |
—
|
—
| 196.71K |
Mar 7
| |||
Form 4
| -16.12% | -13.78K |
$2.68 | -$36,977.18 | 71.71K |
Scheduled
|
Dec 1
| ||
Form 4
| +322.79% | 50K |
—
|
—
| 65.49K |
Apr 1
| |||
Form 4
| -22.55% | -4.51K |
$3.61 | -$502,717.02 | 15.49K |
Scheduled
|
Mar 18
| ||
Form 4
|
—
|
0
|
$2.62 | -$111,324.00 |
0
|
Scheduled
|
Mar 1
| ||
Form 4
| -19.35% | -12.00K |
$2.13 | -$126,099.60 | 50K |
Scheduled
|
Feb 5
| ||
Form 4
| -13.33% | -8.00K |
$1.07 | -$8,546.40 | 52K |
Scheduled
|
Dec 31
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
| +76.45% | 45.87K |
—
|
—
| 105.87K |
Feb 17
| |||
Form 4
|
∞
| 60K |
—
|
—
| 60K |
Nov 28
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Aug 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
ARIAD PHARMACEUTICALS INC No price found
Senior VP, COO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |